Therapeutic prospects of ceRNAs in COVID-19
Since the end of 2019, COVID-19 caused by SARS-CoV-2 has spread worldwide, and the understanding of the new coronavirus is in a preliminary stage. Currently, immunotherapy, cell therapy, antiviral therapy, and Chinese herbal medicine have been applied in the clinical treatment of the new coronavirus...
Main Authors: | Lin Liu, Yao Zhang, Yu Chen, Yueshui Zhao, Jing Shen, Xu Wu, Mingxing Li, Meijuan Chen, Xiaobing Li, Yuhong Sun, Li Gu, Wanping Li, Fang Wang, Lei Yao, Zhuo Zhang, Zhangang Xiao, Fukuan Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.998748/full |
Similar Items
-
Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma
by: Yifan Hu, et al.
Published: (2022-11-01) -
Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma
by: Yao Chen, et al.
Published: (2022-10-01) -
Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs
by: Jing Li, et al.
Published: (2022-09-01) -
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
by: Xiang Wang, et al.
Published: (2024-02-01) -
Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer
by: Yalan Dai, et al.
Published: (2022-11-01)